4//SEC Filing
CONTE LISA A 4
Accession 0001104659-24-063892
CIK 0001585608other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 5:00 PM ET
Size
7.9 KB
Accession
0001104659-24-063892
Insider Transaction Report
Form 4
CONTE LISA A
DirectorCEO and President
Transactions
- Exercise/Conversion
Common Stock
2024-05-17+2,695→ 7,295 total - Exercise/Conversion
Restricted stock units
2024-05-17−2,695→ 2,694 total→ Common Stock (2,695 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On January 23, 2023, the issuer effected a 75-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "January 2023 Reverse Stock Split). Upon effectiveness of the January 2023 Reverse Stock Split, every 75 shares of voting common stock was automatically converted into one share of voting common stock.
- [F3]The restricted stock units were originally approved by the issuer's board of directors on March 28, 2022 and previously reported as covering 606,280 shares, but were adjusted to reflect the January 2023 Reverse Stock Split. The restricted stock units vest in three equal annual installments beginning on May 17, 2023. Vested shares will be delivered to the reporting person on the vesting date provided in the grant notice.
Documents
Issuer
Jaguar Health, Inc.
CIK 0001585608
Entity typeother
Related Parties
1- filerCIK 0001008377
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 5:00 PM ET
- Size
- 7.9 KB